What is the recommended treatment for herpes zoster?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Herpes Zoster

For uncomplicated herpes zoster (shingles), oral antiviral therapy with valacyclovir 1 gram three times daily for 7 days is the recommended first-line treatment. 1

Treatment Algorithm Based on Disease Severity

Uncomplicated Herpes Zoster

  • First-line treatment: Valacyclovir 1 gram orally three times daily for 7 days 1, 2
  • Alternative options:
    • Acyclovir 800 mg orally five times daily for 7 days 1
    • Famciclovir 500 mg orally three times daily for 7 days 3
  • Treatment should be initiated within 72 hours of rash onset for maximum effectiveness 2, 4
  • Continue treatment until all lesions have scabbed 1

Disseminated or Invasive Herpes Zoster

  • Recommended treatment: Intravenous acyclovir 5-10 mg/kg every 8 hours 1
  • Temporary reduction in immunosuppressive medication if applicable 1
  • Continue treatment until clinical resolution is attained 1
  • Switch to oral therapy once clinical improvement occurs 1

Special Populations

Immunocompromised Patients

  • Valacyclovir 1 gram three times daily for 7 days is effective in immunocompromised patients 5
  • Higher dosages (valacyclovir 2 grams three times daily) have not shown additional benefit 5
  • Consider longer treatment duration if healing is delayed 1
  • Monitor closely for dissemination and complications 1

Elderly Patients

  • Valacyclovir has shown better efficacy than acyclovir in patients ≥50 years old 4
  • Median duration of post-herpetic neuralgia is significantly reduced with valacyclovir (38 days) compared to acyclovir (51 days) 4
  • Dosage adjustment may be needed for renal impairment 2

Clinical Benefits of Treatment

  • Accelerates rash healing 4, 6
  • Reduces acute pain during the eruptive phase 4, 6, 3
  • Decreases the duration of post-herpetic neuralgia 4, 6
  • Reduces the proportion of patients with persistent pain at 6 months (19.3% vs 25.7% with acyclovir) 4

Important Considerations

  • Therapy is most effective when initiated within 48-72 hours of rash onset 2, 4
  • However, treatment may still be beneficial when started later than 72 hours after rash onset, especially in patients with new lesion formation or immunocompromised status 3
  • Treatment should be continued until all lesions have scabbed 1
  • No significant benefit has been shown for extending acyclovir treatment beyond 7 days 7

Common Pitfalls and Caveats

  • Failure to initiate treatment promptly (within 72 hours of rash onset) significantly reduces efficacy 2, 4
  • Inadequate dosing frequency (valacyclovir offers simpler dosing than acyclovir) 4, 6, 3
  • Not continuing treatment until all lesions have scabbed 1
  • Antiviral therapy reduces but does not eliminate the risk of post-herpetic neuralgia 4, 3
  • Not adjusting dosage in patients with renal impairment 2

Prevention of Varicella Zoster in Susceptible Patients

  • For varicella-susceptible patients exposed to active varicella zoster infection:
    • Varicella zoster immunoglobulin within 96 hours of exposure 1
    • If immunoglobulin is unavailable or >96 hours have passed, a 7-day course of oral acyclovir begun 7-10 days after exposure 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.